We have reached a point of impasse in treatment of preterm infants and many of their illnesses. Many of the problems we see ...

The systemic lupus erythematosus (SLE) advanced treatment landscape is poised for evolution, with multiple new therapies in development to treat this debilitating ...

A Columbia University-led multicenter research effort called IndiPHARM: individual metabolome and exposome assessment for pharmaceutical optimization will develop a platform and monitoring system to ...

Iantrek, Inc., a venture-backed, medical technology company pioneering next-generation bio- and micro-interventional approaches for the treatment of ophthalmic diseases, today announced that clinical ...

TriArm Therapeutics (“TriArm” or the “Company”), a clinical-stage, next-generation cell therapy company leveraging its global presence and core non-viral platform to advance and democratize CAR-T ...

EyeBio is developing a pipeline of clinical and preclinical candidates for the prevention and treatment of vision loss associated with retinal vascular leakage.

Safe and effective therapeutics are critical when responding to a viral outbreak. But as the COVID-19 pandemic starkly highlighted, the pipeline of therapeutics for diseases with pandemic potential is ...

Silverman, Richard B Candiotti, Keith A and Gitlin, Melvin C 2012. Tapentadol Extended-Release: A Recent Addition to our Analgesic Armamentarium. Pain Management, Vol ...

While spending weeks in the hospital for acute myeloid leukemia, I tried eight fun things to keep me busy. I had acute myeloid leukemia twice. Each time I was diagnosed, I was immediately hospitalized ...